Clarificatory Guidelines on Plea-Bargaining in Drugs Cases
The Supreme Court, during its En Banc deliberations on Tuesday, July 26, 2022, reaffirmed the primacy and exclusivity of its rule-making power under the Constitution, and guaranteed its precedence in governing over the plea bargaining process in drugs cases. In the consolidated cases of People v. Montierro, (G.R No. 254564), Baldadera v. People (G.R. No. 254564); and Re: Letter of the Philippine Judges Association Expressing its Concern over the Ramifications of the Decisions in G.R. No. 247575 and G.R. No. 250295 (A.M. No. 21-07-16-SC), the Supreme Court En Banc underscored the stability and independence of the Court and its rule-making power in resolving the conflict between Department of Justice (DOJ) Circular No. 27, which prohibits plea bargaining for illegal sale of dangerous drugs to the lesser offense of illegal possession of drug paraphernalia under Republic Act No. 9165, or the Comprehensive Dangerous Drugs Act of 2002, and the SC’s Resolution in A.M. No. 18-03-16-SC adopting